Symbols / ECOR Stock $10.25 +0.69% electroCore, Inc.

Healthcare • Medical Devices • United States • NCM
ECOR (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO —
Exch · Country NCM · United States
Market Cap 85.03M
Enterprise Value 85.69M
Income -15.38M
Sales 34.90M
FCF (ttm) -869.75K
Book/sh -0.70
Cash/sh 1.06
Employees 83
Insider 10d —
IPO Jun 22, 2018
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -18.64
PEG —
P/S 2.44
P/B -14.64
P/C —
EV/EBITDA -6.00
EV/Sales 2.46
Quick Ratio 0.79
Current Ratio 1.02
Debt/Eq —
LT Debt/Eq —
EPS (ttm) -1.77
EPS next Y -0.55
EPS Growth —
Revenue Growth 42.60%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-08-05
Earnings (prior) 2026-05-06
ROA -58.08%
ROE —
ROIC —
Gross Margin 87.25%
Oper. Margin -55.47%
Profit Margin -44.08%
Shs Outstand 8.30M
Shs Float 5.17M
Insider Own 37.19%
Instit Own 9.18%
Short Float 3.57%
Short Ratio 2.21
Short Interest 280.33K
52W High 10.45
vs 52W High -1.91%
52W Low 4.16
vs 52W Low 146.39%
Beta 0.87
Impl. Vol. —
Rel Volume 1.48
Avg Volume 103.63K
Volume 153.52K
Target (mean) $19.17
Tgt Median $19.85
Tgt Low $12.00
Tgt High $26.00
# Analysts 5
Recom None
Prev Close $10.18
Price $10.25
Change 0.69%
About

electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga 350, a personal use consumer electronics general wellness product and Truvaga Plus, an app-enabled general wellness product. It also offers non-invasive bioelectronic therapies for the treatment of chronic pain and wellness conditions. In addition, the company offers TAC-STIM for human performance and gammaCore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$19.17
Mean price target
2. Current target
$10.25
Latest analyst target
3. DCF / Fair value
$-1.89
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$10.25
Low
$12.00
High
$26.00
Mean
$19.17

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-01-26 main HC Wainwright & Co. Buy → Buy $18
2025-03-13 main Ladenburg Thalmann Buy → Buy $26
2025-03-13 reit HC Wainwright & Co. Buy → Buy $25
2024-12-18 main HC Wainwright & Co. Buy → Buy $25
2024-03-14 reit HC Wainwright & Co. Buy → Buy $15
2024-01-22 main HC Wainwright & Co. Buy → Buy $15
2023-11-09 main HC Wainwright & Co. Buy → Buy $11
2023-08-10 reit HC Wainwright & Co. Buy → Buy $10
2023-05-04 main HC Wainwright & Co. — → Buy $10
2023-04-18 reit CG Capital — → Outperform $30
2023-04-18 main HC Wainwright & Co. — → Buy $8
2023-03-09 reit HC Wainwright & Co. — → Buy $7
News
RSS: Latest ECOR news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-05-28 LEV JOSHUA S. President — 6,667 $9.00 $60,003
2026-05-22 LEV JOSHUA S. President — 3,000 $6.50 $19,500
2026-05-21 ERRICO THOMAS J. Director — 10,000 $5.98 $59,900
2026-04-13 FOX MICHAEL Chief Operating Officer — 70,000 $0.00 $0
2026-04-10 GOLDBERGER DANIEL S Former — 16,072 $6.02 $96,753
2026-04-01 LEV JOSHUA S. Chief Executive Officer — 45,000 $0.00 $0
2026-03-19 ERRICO THOMAS J. Director — 42,055 $4.35 $222,983
2026-01-26 GOLDBERGER DANIEL S Chief Executive Officer — 46,375 $0.00 $152,201
2026-01-26 LEV JOSHUA S. Chief Financial Officer — 27,889 $0.00 $0
2025-12-04 LEV JOSHUA S. Chief Financial Officer — 2,500 $5.05 $12,625
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
32.03
+27.20%
25.18
+57.09%
16.03
+86.57%
8.59
Operating Revenue
32.03
+27.20%
25.18
+57.09%
16.03
+86.57%
8.59
Cost Of Revenue
4.24
+12.13%
3.79
+34.99%
2.80
+73.51%
1.62
Reconciled Cost Of Revenue
4.24
+12.13%
3.79
+34.99%
2.80
+73.51%
1.62
Gross Profit
27.79
+29.87%
21.40
+61.78%
13.23
+89.59%
6.98
Operating Expense
40.94
+22.00%
33.56
+3.27%
32.49
+8.86%
29.85
Research And Development
2.73
+15.89%
2.36
-55.65%
5.32
-3.61%
5.52
Selling General And Administration
38.21
+22.46%
31.20
+14.81%
27.17
+11.69%
24.33
Total Expenses
45.19
+21.00%
37.34
+5.79%
35.30
+12.18%
31.47
Operating Income
-13.15
-8.15%
-12.16
+36.88%
-19.27
+15.76%
-22.87
Total Operating Income As Reported
-13.15
-8.15%
-12.16
+36.88%
-19.27
+15.76%
-22.87
EBITDA
-11.70
-13.22%
-10.33
+43.37%
-18.24
+18.11%
-22.28
Normalized EBITDA
-11.70
-13.22%
-10.33
+43.37%
-18.24
+18.11%
-22.28
Reconciled Depreciation
1.68
+33.15%
1.26
+22.73%
1.02
+71.98%
0.60
EBIT
-13.37
-15.38%
-11.59
+39.85%
-19.27
+15.76%
-22.87
Total Unusual Items
—
—
—
0.00
Total Unusual Items Excluding Goodwill
—
—
—
0.00
Special Income Charges
—
—
—
0.00
Other Special Charges
—
—
—
—
Restructuring And Mergern Acquisition
—
—
—
—
Net Income
-13.97
-17.50%
-11.89
+36.89%
-18.83
+15.02%
-22.16
Pretax Income
-13.96
-16.56%
-11.98
+37.02%
-19.02
+15.81%
-22.59
Net Non Operating Interest Income Expense
-0.29
-259.56%
0.18
-57.74%
0.43
+50.87%
0.29
Interest Expense Non Operating
0.59
+51.67%
0.39
—
—
Net Interest Income
-0.29
-259.56%
0.18
-57.74%
0.43
+50.87%
0.29
Interest Expense
0.59
+51.67%
0.39
—
—
Interest Income Non Operating
0.30
-47.90%
0.57
+32.10%
0.43
+50.87%
0.29
Interest Income
0.30
-47.90%
0.57
+32.10%
0.43
+50.87%
0.29
Other Income Expense
-0.52
-33.16%
-0.39
-111.41%
-0.18
-2966.67%
-0.01
Other Non Operating Income Expenses
-0.52
-33.16%
-0.39
-111.41%
-0.18
-2966.67%
-0.01
Gain On Sale Of Business
—
—
—
0.00
Tax Provision
0.00
+103.23%
-0.09
+50.00%
-0.19
+56.84%
-0.43
Tax Rate For Calcs
0.00
-100.00%
0.00
-20.00%
0.00
-47.58%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-13.97
-17.50%
-11.89
+36.89%
-18.83
+15.02%
-22.16
Net Income From Continuing Operation Net Minority Interest
-13.97
-17.50%
-11.89
+36.89%
-18.83
+15.02%
-22.16
Net Income From Continuing And Discontinued Operation
-13.97
-17.50%
-11.89
+36.89%
-18.83
+15.02%
-22.16
Net Income Continuous Operations
-13.97
-17.50%
-11.89
+36.89%
-18.83
+15.02%
-22.16
Normalized Income
-13.97
-17.50%
-11.89
+36.89%
-18.83
+15.02%
-22.16
Net Income Common Stockholders
-13.97
-17.50%
-11.89
+36.89%
-18.83
+15.02%
-22.16
Diluted EPS
-1.65
-3.77%
-1.59
+53.51%
-3.42
+27.12%
-4.69
Basic EPS
-1.65
-3.77%
-1.59
+53.51%
-3.42
+27.12%
-4.69
Basic Average Shares
8.48
+13.36%
7.48
+35.68%
5.51
+16.68%
4.73
Diluted Average Shares
8.48
+13.36%
7.48
+35.68%
5.51
+16.68%
4.73
Diluted NI Availto Com Stockholders
-13.97
-17.50%
-11.89
+36.89%
-18.83
+15.02%
-22.16
Earnings From Equity Interest
—
—
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
18.67
-8.81%
20.47
+27.13%
16.10
-34.96%
24.76
Current Assets
15.67
-3.89%
16.30
+14.03%
14.29
-32.49%
21.17
Cash Cash Equivalents And Short Term Investments
11.61
-4.98%
12.22
+18.28%
10.33
-41.67%
17.71
Cash And Cash Equivalents
7.04
+90.14%
3.70
-64.19%
10.33
-41.67%
17.71
Other Short Term Investments
4.58
-46.28%
8.52
0.00
—
Receivables
1.03
-24.87%
1.37
+90.66%
0.72
+78.80%
0.40
Accounts Receivable
1.03
-24.87%
1.37
+90.66%
0.72
+78.80%
0.40
Inventory
1.63
-2.68%
1.68
-22.41%
2.16
+9.31%
1.98
Raw Materials
1.28
+38.46%
0.92
+10.94%
0.83
-1.42%
0.84
Work In Process
0.06
-67.88%
0.19
-87.45%
1.54
+97.43%
0.78
Finished Goods
0.29
-48.04%
0.56
+41.06%
0.40
+12.46%
0.35
Prepaid Assets
—
—
—
—
Restricted Cash
—
0.25
+0.00%
0.25
+0.00%
0.25
Other Current Assets
1.40
+34.59%
1.04
+24.16%
0.84
+0.24%
0.83
Total Non Current Assets
3.00
-28.05%
4.17
+130.70%
1.81
-49.54%
3.58
Net PPE
2.95
-24.38%
3.90
+451.98%
0.71
+14.80%
0.61
Gross PPE
2.95
-24.38%
3.90
+451.98%
0.71
+14.80%
0.61
Other Properties
2.95
-24.38%
3.90
+451.98%
0.71
+14.80%
0.61
Other Non Current Assets
0.05
-80.29%
0.27
-75.14%
1.10
-62.87%
2.97
Total Liabilities Net Minority Interest
20.38
+57.62%
12.93
+49.27%
8.66
+12.91%
7.67
Current Liabilities
11.35
+23.99%
9.15
+12.67%
8.12
+15.30%
7.04
Payables And Accrued Expenses
6.98
+44.10%
4.84
+3.88%
4.66
+15.03%
4.05
Payables
3.24
+46.49%
2.21
-9.28%
2.44
+7.65%
2.26
Accounts Payable
2.71
+48.44%
1.83
-15.53%
2.16
+1.60%
2.13
Current Accrued Expenses
3.74
+42.10%
2.63
+18.29%
2.23
+24.37%
1.79
Pensionand Other Post Retirement Benefit Plans Current
3.58
-2.29%
3.67
+23.05%
2.98
+15.68%
2.58
Total Tax Payable
0.52
+37.17%
0.38
+40.44%
0.27
+104.51%
0.13
Current Debt And Capital Lease Obligation
0.38
+3.88%
0.36
+305.62%
0.09
+20.27%
0.07
Current Capital Lease Obligation
0.38
+3.88%
0.36
+305.62%
0.09
+20.27%
0.07
Current Deferred Liabilities
0.05
-35.90%
0.08
-68.16%
0.24
+61.18%
0.15
Current Deferred Revenue
0.05
-35.90%
0.08
-68.16%
0.24
+61.18%
0.15
Other Current Liabilities
0.36
+77.56%
0.20
+37.58%
0.15
-22.40%
0.19
Total Non Current Liabilities Net Minority Interest
9.03
+139.15%
3.77
+602.98%
0.54
-14.08%
0.62
Long Term Debt And Capital Lease Obligation
9.03
+139.15%
3.77
+602.98%
0.54
-14.08%
0.62
Long Term Debt
6.61
—
—
—
Long Term Capital Lease Obligation
2.42
-35.87%
3.77
+602.98%
0.54
-14.08%
0.62
Stockholders Equity
-1.71
-122.65%
7.54
+1.37%
7.44
-56.44%
17.09
Common Stock Equity
-1.71
-122.65%
7.54
+1.37%
7.44
-56.44%
17.09
Capital Stock
0.01
+14.29%
0.01
+16.67%
0.01
+20.00%
0.01
Common Stock
0.01
+14.29%
0.01
+16.67%
0.01
+20.00%
0.01
Preferred Stock
—
0.00
0.00
0.00
Share Issued
8.00
+20.35%
6.65
+10.80%
6.00
+26.51%
4.74
Ordinary Shares Number
8.00
+20.35%
6.65
+10.80%
6.00
+26.51%
4.74
Additional Paid In Capital
189.24
+2.56%
184.51
+6.84%
172.70
+5.62%
163.52
Retained Earnings
-191.06
-7.89%
-177.09
-7.19%
-165.20
-12.87%
-146.37
Gains Losses Not Affecting Retained Earnings
0.10
-13.16%
0.11
+278.13%
-0.06
+7.25%
-0.07
Minority Interest
—
—
—
—
Other Equity Adjustments
0.10
-13.16%
0.11
+278.13%
-0.06
+7.25%
-0.07
Total Equity Gross Minority Interest
-1.71
-122.65%
7.54
+1.37%
7.44
-56.44%
17.09
Total Capitalization
4.90
-35.07%
7.54
+1.37%
7.44
-56.44%
17.09
Working Capital
4.32
-39.59%
7.15
+15.83%
6.17
-56.32%
14.13
Invested Capital
4.90
-35.07%
7.54
+1.37%
7.44
-56.44%
17.09
Total Debt
9.40
+127.35%
4.14
+560.70%
0.63
-10.44%
0.70
Capital Lease Obligations
2.80
-32.40%
4.14
+560.70%
0.63
-10.44%
0.70
Net Tangible Assets
-1.71
-122.65%
7.54
+1.37%
7.44
-56.44%
17.09
Tangible Book Value
-1.71
-122.65%
7.54
+1.37%
7.44
-56.44%
17.09
Inventories Adjustments Allowances
—
—
-0.61
+72.33%
-2.19
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-8.19
-17.83%
-6.95
+52.63%
-14.67
+11.88%
-16.64
Cash Flow From Continuing Operating Activities
-8.19
-17.83%
-6.95
+52.63%
-14.67
+11.88%
-16.64
Net Income From Continuing Operations
-13.97
-17.50%
-11.89
+36.89%
-18.83
+15.02%
-22.16
Depreciation Amortization Depletion
1.68
+33.15%
1.26
+22.73%
1.02
+71.98%
0.60
Depreciation
1.68
+33.15%
1.26
+22.73%
1.02
+71.98%
0.60
Depreciation And Amortization
1.68
+33.15%
1.26
+22.73%
1.02
+71.98%
0.60
Other Non Cash Items
0.14
—
—
0.05
Stock Based Compensation
1.93
+3.21%
1.87
+10.13%
1.70
-36.69%
2.68
Provisionand Write Offof Assets
0.56
+1005.88%
0.05
-91.88%
0.63
+220.41%
0.20
Asset Impairment Charge
0.15
0.00
—
—
Operating Gains Losses
—
—
—
—
Change In Working Capital
1.32
-24.67%
1.76
+115.83%
0.81
-60.11%
2.04
Change In Receivables
-0.14
+80.00%
-0.71
-170.99%
-0.26
-808.11%
0.04
Changes In Account Receivables
-0.14
+80.00%
-0.71
-170.99%
-0.26
-808.11%
0.04
Change In Inventory
0.02
-97.76%
0.71
+642.71%
0.10
-67.57%
0.30
Change In Prepaid Assets
-0.29
-388.24%
0.10
+1375.00%
-0.01
-103.56%
0.23
Change In Payables And Accrued Expense
3.08
+64.18%
1.88
+76.93%
1.06
-31.35%
1.55
Change In Accrued Expense
0.64
-23.59%
0.83
-19.08%
1.03
+188.48%
0.36
Change In Payable
2.45
+133.78%
1.05
+2894.29%
0.04
-97.06%
1.19
Change In Account Payable
2.45
+133.78%
1.05
+2894.29%
0.04
-97.06%
1.19
Change In Other Current Assets
—
—
—
0.00
Change In Other Current Liabilities
-1.34
-495.56%
-0.23
-208.22%
-0.07
-17.74%
-0.06
Investing Cash Flow
3.88
+145.51%
-8.52
-4035.44%
-0.21
0.00
Cash Flow From Continuing Investing Activities
3.88
+145.51%
-8.52
-4035.44%
-0.21
0.00
Net PPE Purchase And Sale
-0.07
0.00
+100.00%
-0.21
0.00
Purchase Of PPE
-0.07
0.00
+100.00%
-0.21
0.00
Capital Expenditure
-0.07
—
-0.21
—
Net Investment Purchase And Sale
3.94
+146.28%
-8.52
0.00
0.00
Purchase Of Investment
—
-8.52
0.00
0.00
Sale Of Investment
—
—
—
0.00
Gain Loss On Sale Of Business
—
—
—
0.00
Financing Cash Flow
7.63
-9.62%
8.44
+12.72%
7.49
0.00
Cash Flow From Continuing Financing Activities
7.63
-9.62%
8.44
+12.72%
7.49
0.00
Net Issuance Payments Of Debt
7.50
0.00
—
—
Issuance Of Debt
7.50
0.00
—
—
Long Term Debt Issuance
7.50
0.00
—
—
Net Long Term Debt Issuance
7.50
0.00
—
—
Net Common Stock Issuance
0.22
-97.39%
8.30
+1.92%
8.14
0.00
Cash Dividends Paid
—
—
0.00
0.00
Proceeds From Stock Option Exercised
0.10
-73.32%
0.37
0.00
—
Net Other Financing Charges
-0.19
+18.53%
-0.23
+64.69%
-0.66
—
Changes In Cash
3.32
+147.20%
-7.03
+4.86%
-7.39
+55.62%
-16.64
Effect Of Exchange Rate Changes
0.02
-87.76%
0.15
+2350.00%
0.01
+107.32%
-0.08
Beginning Cash Position
3.70
-65.03%
10.58
-41.09%
17.96
-48.22%
34.69
End Cash Position
7.04
+90.14%
3.70
-65.03%
10.58
-41.09%
17.96
Free Cash Flow
-8.25
-18.78%
-6.95
+53.29%
-14.87
+10.64%
-16.64
Interest Paid Supplemental Data
0.40
+2953.85%
0.01
+0.00%
0.01
+116.67%
0.01
Income Tax Paid Supplemental Data
—
—
—
0.00
Amortization Of Securities
—
—
—
0.00
Common Stock Issuance
0.22
-97.39%
8.30
+1.92%
8.14
0.00
Interest Paid CFF
—
—
-0.66
0.00
Issuance Of Capital Stock
0.22
-97.39%
8.30
+1.92%
8.14
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category